Contribution of apolipoprotein E and cathepsin D genotypes to the familial aggregation of Alzheimer's disease

被引:4
|
作者
Heun, R [1 ]
Ptok, U [1 ]
Kölsch, H [1 ]
Maier, W [1 ]
Jessen, F [1 ]
机构
[1] Univ Bonn, Dept Psychiat, DE-53105 Bonn, Germany
关键词
Alzheimer's disease; dementia; depression; genetic polymorphism; apolipoprotein E; cathepsin D; family study;
D O I
10.1159/000079195
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: The familial aggregation of late-onset Alzheimer's disease (AD) might be caused by the clustering of genetic risk factors in families. This study investigates the influence of variants of candidate genes on the familial aggregation of AD. Methods: The occurrence of AD was examined in 1,420 first-degree relatives of 70 AD patients and 144 nondemented controls classified by the presence of AD and relevant candidate genes in index subjects. Results: Relatives of nondemented controls with an apolipoprotein E4 or a cathepsin D T allele had a higher cumulative lifetime incidence of AD than relatives of subjects without the respective alleles. This effect was not detected in relatives of AD patients. Variants of the interleukin-6, bleomycin hydrolase and alpha(2)-macroglobulin genes did not significantly influence the (age-adjusted) risk of AD in relatives. Conclusions: Familial aggregation of late-onset AD is likely to be caused by several genetic risk factors. Variants of the apolipoprotein E and cathepsin D genes influenced the risk of AD in relatives of nondemented control subjects. The lack of an influence of these genotypes on the risk of AD in relatives of AD subjects may be the consequence of complementary reductions of other genetic risk factors such as various, yet unknown susceptibility genes in patients and, consequently, in their first-degree relatives. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:151 / 158
页数:8
相关论文
共 50 条
  • [1] Apolipoprotein E ε4 allele and familial aggregation of Alzheimer disease
    Martinez, M
    Campion, D
    Brice, A
    Hannequin, D
    Dubois, B
    Didierjean, O
    Michon, A
    Thomas-Anterion, C
    Puel, M
    Frebourg, T
    Agid, Y
    Clerget-Darpoux, F
    ARCHIVES OF NEUROLOGY, 1998, 55 (06) : 810 - 816
  • [2] Apolipoprotein E and α1-antichymotrypsin genotypes and age of onset of familial Alzheimer's disease
    Axelman, K
    Basun, H
    Lannfelt, L
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1999, 10 (01) : 1 - 5
  • [3] The vascular contribution of apolipoprotein E to Alzheimer's disease
    Chen, Feng
    Zhao, Jing
    Meng, Fanxia
    He, Fangping
    Ni, Jie
    Fu, Yuan
    BRAIN, 2024, 147 (09) : 2946 - 2965
  • [4] Cathepsin D-mediated proteolysis of apolipoprotein E: Possible role in Alzheimer's disease
    Zhou, W.
    Scott, S. A.
    Shelton, S. B.
    Crutcher, K. A.
    NEUROSCIENCE, 2006, 143 (03) : 689 - 701
  • [5] Cathepsin D polymorphism in Italian sporadic and familial Alzheimer's disease
    Bagnoli, S
    Nacmias, B
    Tedde, A
    Guarnieri, BM
    Cellini, E
    Ciantelli, M
    Petruzzi, C
    Bartoli, A
    Ortenzi, L
    Serio, A
    Sorbi, S
    NEUROSCIENCE LETTERS, 2002, 328 (03) : 273 - 276
  • [6] Apolipoprotein E aggregation in microglia initiates Alzheimer's disease pathology
    Kaji, Seiji
    Berghoff, Stefan A.
    Spieth, Lena
    Schlaphoff, Lennart
    Sasmita, Andrew O.
    Vitale, Simona
    Bueschgens, Luca
    Kedia, Shreeya
    Zirngibl, Martin
    Nazarenko, Taisiia
    Damkou, Alkmini
    Hosang, Leon
    Depp, Constanze
    Kamp, Frits
    Scholz, Patricia
    Ewers, David
    Giera, Martin
    Ischebeck, Till
    Wurst, Wolfgang
    Wefers, Benedikt
    Schifferer, Martina
    Willem, Michael
    Nave, Klaus-Armin
    Haass, Christian
    Arzberger, Thomas
    Jaekel, Sarah
    Wirths, Oliver
    Saher, Gesine
    Simons, Mikael
    IMMUNITY, 2024, 57 (11)
  • [7] Familial and population-based studies of apolipoprotein E and Alzheimer's disease
    Mullan, M
    Scibelli, P
    Duara, R
    Fallin, D
    Gold, M
    Schinka, J
    Hoyne, J
    Osborne, A
    Sevush, S
    Crawford, F
    APOLIPOPROTEIN E GENOTYPING IN ALZHEIMER'S DISEASE, 1996, 802 : 16 - 26
  • [8] Apolipoprotein E and Alzheimer's disease
    Benjamin R.Troutwine
    Laylan Hamid
    Colton R.Lysaker
    Taylor A.Strope
    Heather M.Wilkins
    Acta Pharmaceutica Sinica B, 2022, 12 (02) : 496 - 510
  • [9] Apolipoprotein E and Alzheimer's disease
    Strittmatter, WJ
    Roses, AD
    ANNUAL REVIEW OF NEUROSCIENCE, 1996, 19 : 53 - 77
  • [10] Apolipoprotein E and Alzheimer's disease
    Troutwine, Benjamin R.
    Hamid, Laylan
    Lysaker, Colton R.
    Strope, Taylor A.
    Wilkins, Heather M.
    ACTA PHARMACEUTICA SINICA B, 2022, 12 (02) : 496 - 510